This is a clinical study to evaluate the effects of sorbion sachet s wound dressing on soft tissue edema and wound bioburden in moderately to highly exuding pressure ulcers.

This study is aimed at the participation of subject with moderately to highly exuding pressure ulcers. Each Subject is expected to participate for a period of 4 weeks or until reepithelization, which occurs first.

Inclusion Criteria:

• Subject > 18 years.
• Subject is attending SW Wound Care Center
• Subject has a wound not smaller than 1cm2
• Subject has a wound not larger than 14cm X 23cm
• Subject has a moderately to highly exudative pressure ulcer that would be indicated for treatment with sorbion sachet S
• Subject or subject's legally authorized representative is informed about the trial, understands the nature of the study and provides written informed consent prior to study enrollment.
• Subject is willing and able to comply with all specified care and visit requirements.

Exclusion Criteria:

• Subject has a lesion that does not meet the inclusion criteria.
• Subject has a pressure ulcer that contains areas of undermined tissue.
• Subject refuses to participate in the study.
• Subject is participating in another clinical study.
• Subject already participates in this study with one wound (only one wound per subject is allowed)
• Subject has known sensitivity to the trial product or any of its compounds.
• Subject is expected to be non-compliant.
• Subject uses therapy known to be immunocompromising such as systemic anti cancer drugs and/or systemic corticosteroids.
• Subject suffers from systemic infectious disease(s) known to negatively influence wound healing, such as AIDS.
• Subject's lesion is a primary skin cancer.
• Subject's lesion is the manifestation of a metastasis.
• Subject is pregnant.